TransMedics Group, Inc. (TMDX) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

22/25

Growth 5 Margin 4 Expansion 5 Platform 5 Financial 3

latest quarter score

Earnings Reports

22
TransMedics (TMDX) Q2 2026: Service Revenue Jumps 29% as Logistics Integration Expands Growth Platform
August 05, 2026
22
TransMedics (TMDX) Q1 2026: R&D Investment Surges 45% as Gen 3.0 and CHOPS Expand TAM
May 06, 2026
23
TransMedics (TMDX) Q4 2025: OCS Liver Share Jumps to 36%, Expanding U.S. Transplant Market
February 25, 2026
25
TransMedics (TMDX) Q3 2025: Logistics Revenue Climbs 35% as EU Expansion Takes Shape
October 29, 2025
23
TransMedics (TMDX) Q2 2025: Operating Margin Expands 650bps as OCS Adoption Drives Scale
July 30, 2025
24
TransMedics (TMDX) Q1 2025: Liver Drives 48% Revenue Surge as OCS Platform Expands Clinical Lead
July 05, 2025
TransMedics Group (TMDX) Q4 2024: 50% Revenue Growth Validates Market Penetration Momentum
February 27, 2025

Browse all companies